European Archives - Page 110 of 1608 - European Medical Journal

NHS Braces for Surge in A&E Visits After the World Cup

New data has exposed significant dives in A&E attendances whilst England is playing, leading the NHS to brace for a surge in visits after England matches in the World Cup.

Gene Therapy Shows Promise for Friedreich Ataxia Cardiomyopathy

Gene Therapy Shows Promise for Friedreich Ataxia Cardiomyopathy

A first-in-human gene therapy trial reports safe delivery and early improvements in Friedreich ataxia cardiomyopathy.

EASL 2026 Interview: Sarwa Darwish Murad

The main trend is exactly what we have all been discussing over recent years: MASLD is becoming increasingly prevalent. We already know…

Pregnancy Syphilis Screening Gap Raises Congenital Syphilis Concerns

Pregnancy syphilis screening was nearly universal, but only 22% met all required milestones in a large study in the USA. Key gaps may affect prevention efforts.

Viral Respiratory Hospitalisations Burden Healthcare Systems

Adults hospitalised with viral lower respiratory tract disease face high rates of ICU admission, mortality, and readmission, according to a large US study.

Duodenal Eosinophil Count Linked to Functional Dyspepsia

A case-control study found significantly higher duodenal eosinophil counts in patients with functional dyspepsia, reinforcing evidence for immune involvement in disease pathogenesis.

Next-Generation Rotavirus Vaccines Move Into Focus

International experts have identified key priorities to improve rotavirus vaccine effectiveness, focusing on mucosal immunity and next-generation vaccines.

Metabolic Rewiring of Glycogen as Key Driver of Liver Cancer Growth

Study links AKAP1-driven glycogen reprogramming to liver cancer growth and highlights a potential new targeted therapy for HCC.

Weight-Based Contrast Dosing Preserves CTA Quality and Could Cut Costs

A study found weight-based contrast dosing maintained diagnostic image quality in lower-limb CTA while reducing contrast volume and related costs.

UK Approves First GLP-1 Weight Loss Tablet for Obesity Treatment

UK Approves First GLP-1 Weight Loss Tablet for Obesity Treatment

MHRA approves first GLP-1 weight loss tablet semaglutide for obesity, offering a new oral option for weight management in the UK.